Sepsis is the most common cause of death in
|
|
- Dominic Austin
- 5 years ago
- Views:
Transcription
1 ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic cycling and de-escalation. Antibiotic cycling involves scheduled replacement of 1 or more antibiotics with another for a period of time, in order to avoid the development or control the rate of bacterial resistance. The data to support antibiotic cycling are sparse; its practice is supported more by theory, mostly among physicians in ICUs and pharmacists. Many of the positive results of published studies of cycling can be explained by differences in antibiotic usage or resistance levels at baseline. Also, recent data show an important and unintended consequence of cycling reducing resistance to 1 drug while developing resistance to its replacement. De-escalation involves an aggressive empiric therapy to cover the potential high minimum inhibitory concentration pathogens (eg, frequently Pseudomonas or Acinetobacter in the ICU). At 48 hours, reassessment helps to narrow down the therapeutic options to provide more specific antibiotic coverage, using a less toxic and often less expensive drug with a narrower spectrum. The data to support de-escalation are not widely available. Antibiotic cycling and de-escalation are both widely practiced in ICUs on an ad hoc basis. More careful clinical studies to assess these algorithms are under way. (Adv Stud Med. 2004;4(4A):S256-S261) *Based on a presentation given by Dr Quinn at a symposium held in conjunction with the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Professor, Division of Infectious Diseases, Rush University, Rush-Presbyterian St Luke s Medical Center, Chicago, Illinois. Address correspondence to: John P. Quinn, MD, 1900 West Polk, Room 1258, Chicago, IL john_p_quinn@rush.edu. Sepsis is the most common cause of death in the intensive care unit (ICU). Infectious disease specialists are looking for novel strategies to control sepsis while practicing antimicrobial stewardship in light of the ever-increasing numbers of multiresistant bacteria. Two of the more common strategies for optimizing antimicrobial therapy in this setting are cycling and de-escalation. In order to understand the rationale for these strategies, it is important to understand the mechanisms of resistance. MECHANISMS OF RESISTANCE There are 4 determinants of the minimum inhibitory concentration (MIC) for beta-lactams in Gram-negative bacteria: penetration through the outer membrane, efflux, stability to beta-lactamases, and affinity for penicillin-binding proteins. In Gram-negative bacteria, efflux pumps interact with outer membrane channels (porins), forming multisubunit complexes that allow the bacteria to achieve multidrug resistance. Porins lie in the outer membrane of Gram-negative bacteria (Figure 1). 1 Through the use of accessory proteins, antibacterial agents are pumped out of the cell without ever having penetrated the inner membrane and thus gain access to penicillin-binding proteins. Porins are also able to block toxic compounds by themselves through several types of restriction: size, hydrophobicity, and charge. 1 Efflux pumps have gained much interest in the past decade as their structure and function are better understood, particularly in conjunction with porins and/or enzymatic hydrolysis. When considering antibiotic strategies, these mechanisms of resistance are important factors. ANTIBIOTIC CYCLING Antibiotic cycling involves scheduled replacement of 1 or more antibiotics with another for a period of time to avoid the development of bacterial resistance. The S256 Vol. 4 (4A) April 2004
2 main goal of cycling is to allow resistance rates for specific antibiotics to decrease, or at least remain stable. 2 The data to support antibiotic cycling are sparse; its practice is supported more by theory. While it may be embraced in some ICUs by physicians and pharmacists, molecular biology researchers tend to remain skeptical due to the difference in replication rates of most organisms (eg, every 20 minutes) compared with the cycling rates (eg, every 90 days). Nonetheless, some studies show a benefit with antibiotic cycling. The sentinel study in this area was published more than a decade ago. Gerding et al utilized aminoglycoside cycling in a hospital during a 10-year period. 3 A policy was instituted in which aminoglycosides were rotated based on the resistance pattern within the hospital. Table 1 shows the rotation schedule and declines in resistance during the study. 3 Of note, the reintroduction of gentamicin in study period 3 was rapid, as was the emergence of resistance to gentamicin. A more gradual introduction of gentamicin and removal of amikacin was used in period 5, without a corresponding rise in resistance rates. However, an important limitation of the study is the concomitant decreased usage of aminoglycosides in the hospital during the last 5 years of the study, due to advances in extended-spectrum betalactamase (ESBL) inhibitors and cephalosporins to kill Gram-negative bacteria. 3 The decrease in resistance may have been due in part to the decreased use of aminoglycosides in that environment. In 1997, Kollef and colleagues performed a cycling study in a cardiothoracic surgery unit. 4 A total of 680 patients undergoing cardiac surgery were evaluated for differences in bacteremia and ventilator-associated pneumonia (VAP) due to Gramnegative bacterial infections between two 6-month Figure 1. Schematic of Outer Membrane Porin and Efflux Pump in Gram-negative Bacteria OM = outer membrane. Adapted with permission from Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol. 2001;12(3): Table 1. Resistance of Gram-negative Bacilli to Aminoglycosides During 5 Cycling Periods at the Minneapolis Veterans Affairs Medical Center ( ) Resistant (%) Usage (%) Study Period Months (n) Isolates (n) Amikacin Gentamicin Tobramycin Amikacin Gentamicin Tobramycin 1 (baseline) (amikacin) * 4.8* 92.3* 5.3* 2.4* 3 (gentamicin) * * 66.5* (amikacin) * 4.0* 97.5* 0.9* (gentamicin) * 68.2* 2.0 *P <.001 compared with previous study period; P <.05 compared with previous study period. The observation period was divided into 5 distinct segments defined by predominant aminoglycoside use during that time. Amikacin and gentamicin went through 2 cycles of predominant use. Adapted with permission from the American Society for Microbiology. Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother. 1991;35(7): Advanced Studies in Medicine S257
3 treatment periods: the before period, in which a third-generation cephalosporin (ceftazidime) was given, and the after period, in which a quinolone (ciprofloxacin) was given. Switching from ceftazidime to ciprofloxacin was associated with significant reductions in VAP (11.6% vs 6.7%; P =.028) and VAP attributed to Gram-negative bacteria (4.0% vs 0.9%; P =.013). The reduction in bacteremia due to Gram-negative bacteria was not significant (1.7% vs 0.3%; P =.125). Although the results suggest benefit with antibiotic switching, there was no difference in mortality rate from VAP due to Gram-negative bacteria, length of hospital stay, or development of multiorgan dysfunction between the 2 treatment periods. Importantly, the authors note that the results are preliminary and subject to several study limitations, including a small number of patients and lack of surveillance for any changes in colonization due to antibiotic class switching. 4 More recently, Kollef et al studied the effect of antibiotic cycling in a surgical ICU in a prospective study of 3668 surgical patients. 5 During each of 3 treatment periods, an antibiotic was chosen to treat Gram-negative bacterial infections (ceftazidime, Period 1; ciprofloxacin, Period 2; and cefepime, Period 3). The results showed a nonsignificant decrease in inadequate antimicrobial treatment for nosocomial infections but significant decreases in inadequate treatment for Gram-negative bacterial infections (Figure 2). 5 The mortality rate did not change among the 3 treatment periods, but the mean Acute Physiology and Chronic Health Evaluation (APACHE) II scores decreased across the treatment periods. In fact, the hospital mortality rate decreased significantly across treatment periods for the critically ill patients (APACHE 15), as shown in Figure 3. 5 Not surprisingly, the antibiotic resistance rates correlated with antibiotic use (ie, resistance rates for the particular study drug increased during its use in the study period; Table 2). 5 Rahal et al examined the effect of antibiotic restriction on the rates of resistance. 6 In a university hospital, a new antibiotic guideline excluded the use of cephalosporins without prior authorization by an infectious disease specialist, except for pediatric infection, single-dose surgical prophylaxis, acute bacterial meningitis, spontaneous bacterial peritonitis, and outpatient gonococcal infection. Imipenem also had the Figure 2. Inadequate Antimicrobial Treatment of All Nosocomial Infections According to Study Time Periods All nosocomial infections were microbiologically documented. Inadequate treatment was defined as the use of antibiotics with poor or no in vitro activity against the identified organisms causing infection, such as absence of antimicrobial agents directed at a specific class of microorganisms or administration of an antimicrobial agent to which the microorganism responsible for the infection was resistant. Inadequate treatment of Gram-negative and Gram-positive bacterial infections are also shown. Reproduced with permission from Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000;28(10): Figure 3. Hospital Mortality According to Study Time Periods and APACHE Score APACHE = Acute Physiology and Chronic Health Evaluation. Reproduced with permission from Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000;28(10): S258 Vol. 4 (4A) April 2004
4 same restriction except for use in medical ICU, surgical ICU, and cardiac ICU, with use limited to 72 hours. The rates of ceftazidime-resistant Klebsiella were compared between 1995 (the control period) and 1996 (the study period). With an 80% reduction in cephalosporin use during 1996 (72.5% reduction in ceftazidime use), the study results expectedly show reduced rates of ceftazidime-resistant Klebsiella. Unfortunately, there was a significant, concomitant increase in imipenem-resistant Pseudomonas aeruginosa from 1995 to 1996 (Table 3). 6 The investigators concluded that the class restriction significantly reduced nosocomial, plasmid-mediated, cephalosporin-resistant Klebsiella infection and colonization...at the price of increased imipenem-resistance in P aeruginosa...an overall reduction in multiply-resistant pathogens was achieved in 1 year. 6 However, one might argue that this is an example of shifting the sand on the beach from one hill to another. While not a treatment failure (and not strictly antibiotic cycling), it does serve as a useful example of the unintended consequences of shifting from one class to another. We recently completed a national surveillance study of isolates of Gram-negative bacilli collected during 1994 through 2000 from more than 100 ICUs in 43 states plus the District of Columbia. 7 The study objective was to assess national rates of antimicrobial resistance among these isolates and compare them with rates of antimicrobial use. The results showed that amikacin and imipenem were the most active agents among all isolates and the 4 most common pathogens (Table 4) and that the activity of most agents decreased by 6% or less over the study period, with the exception of ciprofloxacin. 7 Among all isolates, the percentage of susceptibility to ciprofloxacin decreased by 10%; susceptibility decreased from 81% to 76% among P aeruginosa isolates. Importantly, ciprofloxacin resistance was associated with the 2.5-fold increase in fluoroquinolone use and cross-resistance to other broad-spectrum antimicrobial agents (Table 5). 7 As we noted, cross-resistance between fluoroquinolones and other classes has been associated with specific mechanisms of resistance (eg, ESBLs, plasmid-mediated resistance, increased efflux capability). 7 The next question is whether antibiotic cycling will affect these trends in resistance. The Centers for Disease Control and Prevention are sponsoring a 2-year cycling study at 3 US institutions. During the study, cefepime, imipenem, piperacillin/tazobactam, and ciprofloxacin will be rotated every 90 days, and outcomes, costs, and effect on flora (resistance and crossresistance patterns and mechanisms) will be measured. All clinical isolates will be saved, including weekly rectal swabs made before, during, and after antibiotic rotation, for organisms resistant to any of the 4 antibiotics under Table 2.Antibiotic Cycling and Resistance Patterns in a Surgical Intensive Care Unit Period 1 Period 2 Period 3 Ceftazidime Ciprofloxacin Cefepime Resistant Organism, n (%) (n = 1323) (n = 1243) (n = 1102) Gram-negative bacilli 35 (2.6) 4 (0.3)* 8 (0.7) resistant to thirdgeneration cephalosporin Gram-negative bacilli 2 (0.2) 14 (1.1)* 4 (0.4) resistant to ciprofloxacin Gram-negative bacilli 0 (0.0) 2 (0.2) 10 (0.9) resistant to cefepime *P <.05 comparing patients in Period 2 with Period 1; P <.05 comparing patients in Period 3 with Period 1; P <.05 comparing patients in Period 3 with Period 2 Adapted with permission from Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000;28(10): Table 3. Source of Resistant Isolates in 1995 and 1996 During Cephalosporin Restriction Ceftazidime-Resistant Imipenem-Resistant Source of Klebsiella Pseudomonas aeruginosa patient isolates Nosocomial Nursing home acquired* Outpatient Emergency Nursing home Total *A resistant isolate from a hospitalized patient within 72 hours after transfer from a nursing home. Isolates from patients in an affiliated nursing home, not admitted to the hospital. Reprinted with permission from Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14): Advanced Studies in Medicine S259
5 rotation. To date, compliance is about 70% in the study. (Of note, in the published literature, compliance information is often lacking.) This study will allow us to understand the impact of antibiotic rotation on resistance selection (eg, the ability of cefepime to select ESBL-producing organisms) and the mechanisms of resistance (eg, independent mutations for cross-resistance). This study is under way and results are not yet available. ANTIBIOTIC DE-ESCALATION De-escalation is a new concept in antibiotic stewardship, so the data for this strategy are not widely available for review. Nonetheless, the concept is rather simple. Historically, treatment algorithms have employed a drug escalation strategy in which the most likely pathogen is surmised, based on the patient s level of sickness, use of steroids, presence of neutropenia, hospital setting, duration of hospitalization, and local resistance patterns. The most elegant antibiotic is chosen based on susceptibility spectrum, toxicity, and cost. At 48 hours, the patient is reassessed with culture results and clinical response. If the patient is responding, the regimen is continued. If not (ie, poor outcome or emergence of resistance), a more aggressive regimen is chosen. An important disadvantage with this approach is the loss of those first 48 hours, during which resistance can emerge or septic death can occur. Conversely, de-escalation involves an aggressive empiric therapy to cover the potential high-mic pathogens (eg, frequently Pseudomonas or Acinetobacter in the ICU). As with drug escalation, the clinician reassesses at 48 hours with culture results and clinical response. The culture results help to narrow the therapeutic options to provide more Table 4.Antimicrobial Susceptibility Rates for All and for the 4 Most Common Species of Gram-negative Bacilli, ICU Surveillance All Isolates Absolute Pseudomonas Enterobacter Klebsiella Escherichia All Isolates, % Change in aeruginosa, % Species, % pneumoniae, % coli, % Antimicrobials (N = ) % Susceptible (n = 8244) (n = 4999) (n = 4877) (n = 4027) Group 1, 90% susceptibility Amikacin Group 2, 80%-90% susceptibility Imipenem Tobramycin Ciprofloxacin Group 3 79% susceptibility Cefepime 78 2* Ceftazidime Gentamicin Piperacillin/tazobactam Aztreonam Ticarcillin/clavulante Piperacillin Ceftriaxone Cefotaxime Ticarcillin Ampicillin/sulbactam *Based on % change, ; Based on % change, ICU = intensive care unit. Reprinted with permission from Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units. Implications for fluoroquinolone use. JAMA. 2003;289(7): S260 Vol. 4 (4A) April 2004
6 Table 5. Examples of Antimicrobial Crossresistance Among Selected Gram-negative Bacilli, ICU Surveillance Pseudomonas aeruginosa Enterobacter species Klebsiella pneumoniae Ciprofloxacin- Ciprofloxacin- Ciprofloxacin- Ciprofloxacin- Ciprofloxacin- Ciprofloxacin- Antimicrobial Resistant, % Susceptible, % Resistant, % Susceptible, % Resistant, % Susceptible, % Resistance (n = 1946) (n = 6298) (n = 486) (n = 4513) (n= 603) (n = 4274) Gentamicin Ceftazidime Imipenem Amikacin ICU = intensive care unit. Reprinted with permission from Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units. Implications for fluoroquinolone use. JAMA. 2003;289(7): specific antibiotic coverage, using a less toxic and often less expensive drug with a narrower spectrum. 8 CONCLUSION Multiresistant organisms appear to arise not from a single genetic event but from a cascade of events. Using P aeruginosa as an example, initial use of cephalosporins may select derepressed type 1 betalactamase mutants or, less commonly, a plasmidmediated ESBL. Treatment with a quinolone will induce an antibiotic efflux pump. Treatment with a carbapenem such as imipenem will downregulate the D 2 porin, thus leading to multidrug resistance. Antibiotic cycling and de-escalation are both widely practiced in ICUs on an ad hoc basis. The current data to support these strategies are preliminary, but the strategies are in use nonetheless. As a result, more careful clinical studies to assess these algorithms are under way. REFERENCES 1. Nikaido H. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin Cell Dev Biol. 2001;12(3): Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med. 2001;29(4 suppl):n135-n Gerding DN, Larson TA, Hughes RA, Weiler M, Shanholtzer C, Peterson LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother. 1991;35(7): Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156(4 pt 1): Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000; 28(10): Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14): Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units. Implications for fluoroquinolone use. JAMA. 2003;289(7): Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care. 2001;5(4): Advanced Studies in Medicine S261
Appropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationLearning Points. Raymond Blum, M.D. Antimicrobial resistance among gram-negative pathogens is increasing
Raymond Blum, M.D. Learning Points Antimicrobial resistance among gram-negative pathogens is increasing Infection with antimicrobial-resistant pathogens is associated with increased mortality, length of
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationLack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
Infect Dis Ther (2014) 3:55 59 DOI 10.1007/s40121-014-0028-8 BRIEF REPORT Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
More informationNational Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2004, p. 4606 4610 Vol. 48, No. 12 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.12.4606 4610.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationMono- versus Bitherapy for Management of HAP/VAP in the ICU
Mono- versus Bitherapy for Management of HAP/VAP in the ICU Jean Chastre, www.reamedpitie.com Conflicts of interest: Consulting or Lecture fees: Nektar-Bayer, Pfizer, Brahms, Sanofi- Aventis, Janssen-Cilag,
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationReport on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"
Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationUpdate on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia. Po-Ren Hsueh. National Taiwan University Hospital
Update on Resistance and Epidemiology of Nosocomial Respiratory Pathogens in Asia Po-Ren Hsueh National Taiwan University Hospital Ventilator-associated Pneumonia Microbiological Report Sputum from a
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More information10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)
Beta-lactam antibiotics Penicillins Target - Cell wall - interfere with cross linking Actively growing cells Bind to Penicillin Binding Proteins Enzymes involved in cell wall synthesis Activity of an Antibiotic
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationAntimicrobial stewardship in managing septic patients
Antimicrobial stewardship in managing septic patients November 11, 2017 Samuel L. Aitken, PharmD, BCPS (AQ-ID) Clinical Pharmacy Specialist, Infectious Diseases slaitken@mdanderson.org Conflict of interest
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationCARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)
CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE) Bartsch SM et al. Potential economic burden of carbapenem-resistent Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect 2017;23(1):48e9-e16.
More informationSuccessful stewardship in hospital settings
Successful stewardship in hospital settings Pr Charles-Edouard Luyt Service de Réanimation Institut de Cardiologie Groupe Hospitalier Pitié-Salpêtrière Université Pierre et Marie Curie, Paris 6 www.reamedpitie.com
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationApproach to pediatric Antibiotics
Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus
More informationGUIDELINES EXECUTIVE SUMMARY
GUIDELINES Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship Timothy
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationRational use of antibiotics
Rational use of antibiotics Uga Dumpis MD, PhD,, DTM Stradins University Hospital Riga, Latvia ugadumpis@stradini.lv BALTICCARE CONFERENCE, PSKOV, 16-18.03, 18.03, 2006 Why to use antibiotics? Prophylaxis
More informationBest Practices: Goals of Antimicrobial Stewardship
Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationManagement of Hospital-acquired Pneumonia
Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationMDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationGrey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report to 214 Table of Contents I. Introduction..
More informationGUIDELINES EXECUTIVE SUMMARY
GUIDELINES Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship Timothy
More informationSHC Clinical Pathway: HAP/VAP Flowchart
SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal
More informationSustaining an Antimicrobial Stewardship
Sustaining an Antimicrobial Stewardship Much needless expense, untoward effect, harm and disappointment can be prevented by better judgment in the use of antimicrobials Whitney A. Jones, PharmD Antimicrobial
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationMeasurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist
Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationPreserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP
Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP Clinical Associate Professor Infectious Diseases Specialist The Ohio State University Medical
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical
More informationSt. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report
St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationBacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota
Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated
More information10 Golden rules of Antibiotic Stewardship in ICU. Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017
10 Golden rules of Antibiotic Stewardship in ICU Jeroen Schouten, MD PhD intensivist, Nijmegen (Neth) Istanbul, Oct 6th 2017 10 golden rules of Antibiotic Stewardship in the ICU ID, Pharma & Micro advice
More informationPotential Conflicts of Interest. Schematic. Reporting AST. Clinically-Oriented AST Reporting & Antimicrobial Stewardship
Potential Conflicts of Interest Clinically-Oriented AST Reporting & Antimicrobial Stewardship Hsu Li Yang 27 th September 2013 Research Funding: Pfizer Singapore AstraZeneca Janssen-Cilag Merck, Sharpe
More informationJournal of Antimicrobial Chemotherapy Advance Access published April 14, 2008
Journal of Antimicrobial Chemotherapy Advance Access published April 14, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn164 Control of extended-spectrum b-lactamase-producing Klebsiella
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationOPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS
HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationAntimicrobial stewardship in companion animals: Welcome to a whole new era
Antimicrobial stewardship in companion animals: Welcome to a whole new era John F. Prescott, University Professor Emeritus, Department of Pathobiology, University of Guelph, Guelph, Ontario NG 2W1 prescott@uoguelph.ca
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationAntibiotic treatment in the ICU 1. ICU Fellowship Training Radboudumc
Antibiotic treatment in the ICU 1 ICU Fellowship Training Radboudumc Main issues Delayed identification of microorganisms Impact of critical illness on Pk/Pd High prevalence of antibiotic resistant strains
More informationInfectious Diseases Society of America Emerging Infections Network. Comments for Query: The Challenge of Multidrug-Resistant Enterobacteriaceae
Infectious Diseases Society of America Emerging Infections Network Comments for Query: The Challenge of Multidrug-Resistant Enterobacteriaceae What do you view as the most important problem with regard
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: SHOBHA K L, RAMACHANDRA L, RAO G, MAJUMDER S, RAO S P. EXTENDED SPECTRUM BETA-LACTAMASES (ESBL) IN GRAM NEGATIVE BACILLI AT A TERTIARY
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationScottish Medicines Consortium
Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationPrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia
: K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:
More information